NCT05608694Active, not recruiting
MRI Screening in Men at High Risk of Developing Prostate Cancer
Source: ClinicalTrials.gov · Last updated 13 Oct 2026
Brief summary (registry, in English)
The purpose of this study is to determine whether or not Magnetic Resonance Images (MRI) will identify high-grade cancers earlier and more frequently in men at high risk of developing prostate cancer.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- First submitted
- 10 Oct 2022
- Start date
- 2 Mar 2022
- Primary completion date
- 1 Mar 2037
- Lead sponsor
- University of Chicago
- Diseases
- Prostate cancer
- NCT number
- NCT05608694
What you commit to
- Study type: Interventional
- Planned participants: 250
- From 2 Mar 2022 to the primary completion date, 1 Mar 2037
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Unable to tolerate MRI due to metal fragments or claustrophobia
- Lack of a rectum
- Hip arthroplasty
Who the study is looking for
- Male age 18 and older
- No known history of prostate cancer
- No previous prostate resection or ablation (e.g. TURP, photovaporization)
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Chicago Coordinator of this site? Confirm its status | Chicago | United States | Unknown status |
| NorthShore University Health System - Glenbrook Hospital Coordinator of this site? Confirm its status | Glenview | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.